Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 1 to 10 of 41 resources

  • Drug-related infectious diseases in Europe: Update from the EMCDDA expert network, 2020
    This 2020 update on drug-related infectious diseases from the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020. It highlights some recent innovative responses to the problem and argues that early diagnosis through testing as well as improving links to treatment and care are crucial steps towards reaching global health goals.
    UK, Rest of World Reports & Research, Strategy & Planning PDF
  • World Hepatitis Alliance: 2019 Impact report
    This report provides an overview of the World Hepatitis Alliance's impact in 2019, summarising key achievements in raising the importance of hepatitis elimination around the world.
    Rest of World 08 Apr 2020 Reports & Research PDF
  • World Hepatitis Day 2019: Global Summary Report
    The World Hepatitis Alliance has produced a report summarising activity for World Hepatitis Day 2019, including a global map of activity and regional reports.
    Rest of World 19 Dec 2019 Reports & Research PDF
  • Legal Barriers for Providing HCV Community Testing in Europe
    This report from the Correlation European Harm Reduction Network is based on a telephone survey conducted in September and October 2018 with representatives of harm reduction services and NGOs that offer low-threshold services to drug users.
    UK, Rest of World Reports & Research PDF
  • EMCDDA on models of care for hepatitis C in drugs services
    The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.
    UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF
  • Drug-related infectious diseases in Europe
    This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.
    UK, Rest of World 16 Jul 2019 Reports & Research PDF
  • Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners
    This study evaluates peer-supported screening as a model of active HCV case finding within prisons with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes. The study was carried out in a medium-security Irish male prison with over 500 inmates. The authors conclude that peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.
    Rest of World 09 Jul 2019 Reports & Research PDF
  • WHO progress report on HIV, viral hepatitis and STIs 2019
    The World Health Organisation has published its mid-term report on progress towards implementing the 'Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections'. The UK signed up to the 'Global health sector strategy on viral hepatitis 2016-21', committing to eliminating hepatitis C by 2030. The report highlights the need to strengthen data and update hepatitis data more regularly. It states that global targets for reducing mortality from viral hepatitis will not be met 'without massively accelerating universal access to testing' and treatment.
    Rest of World 24 May 2019 Reports & Research, Strategy & Planning PDF
  • WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
    The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.
    UK, Rest of World 17 May 2019 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Hepatitis C Annual Epidemiological Report for 2017
    The European Centre for Disease Prevention and Control has published a new report on the prevalence of hepatitis C in Europe. The report indicates a 10% decrease in newly reported hepatitis C cases from 2016 to 2017, but also warns of the under-reporting of diagnosed cases and the variation of national testing practices impacting the reliability of this statistic. Headline figures show that 5.6 million Europeans live with chronic hepatitis C, with more than 31,000 recorded cases in 2017.
    Rest of World 05 Apr 2019 Reports & Research PDF

Pages